Breaking News Instant updates and real-time market news.

AMRX

Amneal Pharmaceuticals

$4.36

-2.44 (-35.88%)

07:11
07/11/19
07/11
07:11
07/11/19
07:11

Amneal Pharmaceuticals price target lowered to $9 from $16 at SunTrust

SunTrust analyst Gregg Gilberg lowered his price target on Amneal Pharmaceuticals to $9 after its restructuring announcement yesterday, saying the company's base generics business continues to face pressure while its launches are being delayed. The analyst maintains his Buy rating, but says his stance is predicated on a "robust flow of new product launches" beyond 2019 and the company's ability to execute amid the improved industry dynamics.

  • 08

    Aug

AMRX Amneal Pharmaceuticals
$4.36

-2.44 (-35.88%)

07/10/19
WELS
07/10/19
NO CHANGE
WELS
Amneal news reflects challenges in generics industry, says Wells Fargo
Wells Fargo analyst David Maris believes the cost cutting and restructuring plans announced this morning by Amneal Pharmaceuticals (AMRX) reflect the ongoing challenges in the generics industry as a whole. Amneal said the actions are the result of "continuing industry challenges," including ongoing pressure in generics from "the limited number of buyers and the greater than expected effect of additional competition on our key generic products," as well as the complex generic pipeline taking longer to materialize, Maris tells investors in a research note. The analyst's review of recent IMS data leads him to believe the environment remains challenging. In the generic space Maris has only one Outperform-rated name, Amphastar (AMPH), since the company specializes in "non-commodity" generics.
07/10/19
RAJA
07/10/19
DOWNGRADE
RAJA
Outperform
Amneal downgraded to Outperform from Strong Buy at Raymond James
07/10/19
RAJA
07/10/19
DOWNGRADE
Target $8.5
RAJA
Outperform
Raymond James downgrades Amneal to Outperform after guidance cut
As previously reported, Raymond James analyst Elliot Wilbur downgraded Amneal Pharmaceuticals to Outperform from Strong Buy after the company announced "a rather substantial reduction to near-term EBITDA guidance," which he said looked worse than even the "most pessimistic scenarios." While he lowered his price target on Amneal shares to $8.50 from $13, Wilbur also said he still thinks the company has the potential for "best-in-class" ANDA approvals over next two to three years.
07/11/19
RBCM
07/11/19
DOWNGRADE
Target $6
RBCM
Sector Perform
Amneal downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Randall Stanicky downgraded Amneal Pharmaceuticals to Sector Perform from Outperform and lowered his price target for the shares to $6 from $11. Yesterday's guidance cut implies a "meaningful step-down," which boosts the company's leverage, Stanicky tells investors in a research note. He thinks Amneal can navigate the pressure facing the generic industry, but feels it will take time.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/18/19
07/18
14:16
07/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEIX

Pacific Ethanol

$0.66

-0.0008 (-0.12%)

14:14
07/18/19
07/18
14:14
07/18/19
14:14
Hot Stocks
Hightower Advisors reports 8.17% passive stake in Pacific Ethanol »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$204.77

1.45 (0.71%)

, SWKS

Skyworks

$81.00

0.85 (1.06%)

14:12
07/18/19
07/18
14:12
07/18/19
14:12
On The Fly
Street Fight: Apple upgraded on 5G iPhone hopes as analysts diverge on Skyworks »

Citing greater confidence…

AAPL

Apple

$204.77

1.45 (0.71%)

SWKS

Skyworks

$81.00

0.85 (1.06%)

QCOM

Qualcomm

$74.67

-1.08 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 07

    Aug

QCOM

Qualcomm

$74.67

-1.08 (-1.43%)

14:09
07/18/19
07/18
14:09
07/18/19
14:09
Initiation
Qualcomm initiated  »

Qualcomm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MSFT

Microsoft

$135.02

-1.21 (-0.89%)

, AMZN

Amazon.com

$1,958.83

-33.58 (-1.69%)

14:05
07/18/19
07/18
14:05
07/18/19
14:05
Periodicals
Trump says he's considering looking into Pentagon's JEDI contract, CNBC says »

U.S. President Donald…

MSFT

Microsoft

$135.02

-1.21 (-0.89%)

AMZN

Amazon.com

$1,958.83

-33.58 (-1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 25

    Jul

  • 06

    Aug

  • 08

    Aug

EGBN

Eagle Bancorp

$44.62

-8.81 (-16.49%)

14:02
07/18/19
07/18
14:02
07/18/19
14:02
Downgrade
Eagle Bancorp rating change  »

Eagle Bancorp downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Aug

  • 11

    Sep

  • 23

    Sep

14:00
07/18/19
07/18
14:00
07/18/19
14:00
General news
Breaking General news story  »

New York Federal Reserve…

13:55
07/18/19
07/18
13:55
07/18/19
13:55
Conference/Events
Federal Reserve Bank of New York president delivers keynote address »

New York Federal Reserve…

CAMP

CalAmp

$10.59

-0.23 (-2.13%)

13:55
07/18/19
07/18
13:55
07/18/19
13:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

ADMP

Adamis Pharmaceuticals

$1.22

-0.03 (-2.41%)

13:54
07/18/19
07/18
13:54
07/18/19
13:54
Hot Stocks
Adamis Pharmaceuticals, kaleo Inc agree to settle all litigation »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

PPG

PPG

$116.58

-0.025 (-0.02%)

13:54
07/18/19
07/18
13:54
07/18/19
13:54
Earnings
PPG sees unfavorable currency translation impact on Q3 sales of $30M-$50M »

"Looking ahead,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

PPG

PPG

$116.49

-0.115 (-0.10%)

13:49
07/18/19
07/18
13:49
07/18/19
13:49
Hot Stocks
PPG says Q2 EPS impacted by lower global industrial production »

According to prepared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 05

    Aug

ZBRA

Zebra Technologies

$180.92

-16.74 (-8.47%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Options
Notable vol spike in Zebra Technologies as shares sell off »

Notable vol spike in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

TELL

Tellurian

$6.98

0.31 (4.65%)

13:40
07/18/19
07/18
13:40
07/18/19
13:40
Recommendations
Tellurian analyst commentary at Stifel »

Tellurian higher after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JLL

Jones Lang LaSalle

$140.05

0.585 (0.42%)

13:32
07/18/19
07/18
13:32
07/18/19
13:32
Conference/Events
Jones Lang LaSalle management to meet with Mizuho »

Meeting with EVP Monahan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

GOSS

Gossamer Bio

$19.60

-0.48 (-2.39%)

13:30
07/18/19
07/18
13:30
07/18/19
13:30
Options
Gossamer Bio call volume spikes on November purchase wit shares at 52wk lows »

Gossamer Bio call volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/18/19
07/18
13:25
07/18/19
13:25
Conference/Events
Cowen healthcare/biotech analysts to hold an analyst/industry conference call »

Healthcare Technology…

PEP

PepsiCo

$132.17

-0.6 (-0.45%)

13:24
07/18/19
07/18
13:24
07/18/19
13:24
Periodicals
Breaking Periodicals news story on PepsiCo »

PepsiCo in talks to buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
07/18/19
07/18
13:20
07/18/19
13:20
General news
Treasury's $14 B 10-year TIPS sale was on the soft side »

Treasury's $14 B…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/18/19
07/18
13:17
07/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/18/19
07/18
13:16
07/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$8.55

-0.03 (-0.35%)

13:15
07/18/19
07/18
13:15
07/18/19
13:15
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:09
07/18/19
07/18
13:09
07/18/19
13:09
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

TELL

Tellurian

$6.99

0.32 (4.80%)

13:05
07/18/19
07/18
13:05
07/18/19
13:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.